[Skip to Content]
[Skip to Content Landing]
November 1941


Arch Otolaryngol. 1941;34(5):1039-1064. doi:10.1001/archotol.1941.00660041113017

For the last eight years at the Roentgen and Light Institute, in Cologne, Germany, Coutard protracted roentgen therapy has been in use. Glauner, Teufel and Daigger1 reported its use in cases of malignant tumors of the mouth, pharynx, hypopharynx and larynx. In analyzing their statistics, they found that results of the treatment of cancers of the mouth, pharynx and hypopharynx by Coutard's method do not compare favorably with results from surgical intervention reported by other clinics. A possible exception was made for carcinomas of the larynx and highly malignant types of growth in the pharynx and the tonsillar region. In cases of growths in these locations, they asserted, any comparison of the Coutard therapy with surgical intervention is not entirely convincing, since operation often is attempted first.

Lierle2 reviewed 169 cases of epidermoid carcinoma which involved the buccal mucosa, pharynx or larynx. All patients had been observed for three to

First Page Preview View Large
First page PDF preview
First page PDF preview